Inventor · disambiguated record
Chrishan Samuel
Also filed as: SAMUEL CHRISHAN · SAMUEL CHRISHAN S · SAMUEL CHRISHAN SURENDRAN
5 granted patents·6 pending applications·4 citations·filing 2001–2018
69Inventor score
Files withFLOREY HOWARD INST2AMENTO EDWARD P1ASTRAZENECA AB1BAKER MED RES INST1BATHGATE ROSS ALEXANDER DAVID1
Top patents by PatentIndex Score
11 records- 0168US7833526B2Methods of modulating apoptosis by administration of relaxin agonists or antagonistsMOLECULAR MEDICINE RES INST·Filed 2007·Granted Nov 16, 2010·2 cites·6 claims
- 0266US9056922B2Chimeric relaxin polypeptides comprising an A and B chain derived from different relaxin family peptidesBATHGATE ROSS ALEXANDER DAVID·Filed 2008·Granted Jun 16, 2015·2 cites·13 claims
- 0359US2011003750A1Human 3 relaxinFLOREY HOWARD INST·Filed 2009·Application pending·0 cites
- 0458US2009239805A1Human 3 relaxinFLOREY HOWARD INST·Filed 2009·Application pending·0 cites
- 0550US8841254B2Method for treatment of anxietyTREGEAR GEOFFREY·Filed 2007·Granted Sep 23, 2014·0 cites·32 claims
- 0649US9534034B2Methods of modulating apoptosis by administration of relaxin agonists or antagonistsAMENTO EDWARD P·Filed 2012·Granted Jan 3, 2017·0 cites·7 claims
- 0746US2005026822A1Human 3 relaxinASTRAZENECA AB·Filed 2002·Application pending·0 cites
- 0846US2006264367A1Prevention of fibrosis following cardiac injuryBAKER MED RES INST·Filed 2005·Application pending·0 cites
- 0945US2005032683A1Methods of modulating apoptosis by administration of relaxin agonists or antagonistsFiled 2001·Application pending·0 cites
- 1044US11471493B2Method for treating allergic airways disease (AAD)/asthmaCYNATA THERAPEUTICS LTD·Filed 2018·Granted Oct 18, 2022·0 cites·22 claims
- 1133US2019307811A1Method for treating airways diseaseHUDSON INST MED RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chrishan Samuel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →